>Marché des services de laboratoire clinique au Moyen-Orient et en Afrique, par spécialité (tests de chimie clinique, tests d'hématologie, tests de microbiologie , tests d'immunologie, tests de drogues, tests de cytologie et tests génétiques ), fournisseur (laboratoires indépendants et de référence, laboratoires hospitaliers et laboratoires de soins infirmiers et de cabinet médical), application (services liés à la découverte de médicaments, services liés au développement de médicaments, services de chimie bioanalytique et de laboratoire, services de tests toxicologiques, services liés à la thérapie cellulaire et génique, services liés aux essais précliniques et cliniques et autres services de laboratoire clinique), type de service (services de tests de routine, services ésotériques et services d'anatomie pathologique), pays (Brésil, Argentine, reste de l'Amérique du Sud, Afrique du Sud, Arabie saoudite, Émirats arabes unis, Égypte, Israël et reste du Moyen-Orient et de l'Afrique) Tendances de l'industrie et prévisions jusqu'en 2028.
Analyse et perspectives du marché : marché des services de laboratoire clinique au Moyen-Orient et en Afrique
Le marché des services de laboratoire clinique devrait connaître une croissance du marché au cours de la période de prévision de 2021 à 2028. Data Bridge Market Research analyse que le marché croît avec un TCAC de 4,7 % au cours de la période de prévision de 2021 à 2028 et devrait atteindre 7 551,56 millions USD d'ici 2028. L'augmentation des maladies infectieuses dans le monde et les progrès des méthodes de diagnostic clinique agissent comme un moteur de la croissance du marché des services de laboratoire clinique au Moyen-Orient et en Afrique.
Les laboratoires cliniques sont un élément important du secteur de la santé. La plupart des tests de diagnostic, de l'analyse sanguine à l'analyse génétique, sont effectués dans ces laboratoires cliniques pour détecter différentes maladies. Les laboratoires cliniques offrent des données et des ressources qui permettent d'optimiser la distribution requise dans le système de santé, comme les diagnostics et les résultats des tests. Cela permet de conserver et de fournir des résultats de test fiables et corrects qui permettent aux médecins de prendre des décisions cliniques et diagnostiques appropriées à différents niveaux des services de soins de santé. Cela permet aux cliniciens d'adapter, de commencer et également d'arrêter un traitement qui serait entravé en l'absence d'installations de laboratoire médical. Les services de laboratoire clinique comprennent la découverte de médicaments, le développement de médicaments, la chimie bioanalytique et de laboratoire, les tests de toxicologie, la thérapie cellulaire et génique et les services liés aux essais précliniques et cliniques. Les laboratoires indépendants et de référence, les laboratoires hospitaliers, les laboratoires infirmiers et les laboratoires de cabinet médical sont quelques-uns des principaux fournisseurs de services de laboratoire clinique.
The growth of the Middle East and Africa clinical laboratory services market reflects increase in occurrence of infectious diseases and rising demand for early and accurate disease diagnosis along with advancement in the methods of clinical diagnostics. Additionally, major factors expected to contribute in growth of the Middle East and Africa clinical laboratory services market in future are rising adoption of digital pathology platforms, preference for comprehensive health checkups offered by clinical laboratories. Inaccurate results of tests along with inadequate reimbursements policies is expected to restrain Middle East and Africa clinical laboratory services market growth. However, pricing pressure faced by healthcare payers and providers and rise in preference for home-based/point-of-care testing procedures are expected to obstruct the market growth.
The clinical laboratory services market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the clinical laboratory services market scenario contact Data Bridge Market Research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.
Clinical Laboratory Services Market Scope and Market Size
The clinical laboratory services market is segmented on specialty, provider, application and service type. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of specialty, the market is segmented into clinical chemistry testing, hematology testing, microbiology testing, immunology testing, drugs of abuse testing, cytology testing and genetic testing. In 2021, the clinical chemistry testing segment is expected to dominate the market due to the increasing demand of point of care testing solutions which is used for the fast diagnosis of the disease is expected to help the market to grow significantly.
- On the basis of provider, the market is segmented into independent & reference laboratories, hospital-based laboratories and nursing and physician office-based laboratories. In 2021, the hospital-based laboratories segment is expected to dominate the market due to increasing cases of injuries in the hospitals which leads to high patient volumes.
- On the basis of application, the market is segmented into drug discovery related services, drug development related services, bioanalytical & lab chemistry services, toxicology testing services, cell & gene therapy related services, preclinical & clinical trial related services and other clinical laboratory services. In 2021, the bioanalytical & lab chemistry services segment is expected to dominate the market because lab chemistry services provide support in the chemical analysis including elemental analysis, failure analysis and project analysis.
- On the basis of service type, the market is segmented into routine testing services, esoteric services and anatomic pathology services. In 2021, the routine testing services segment is expected to dominate the market due to increasing demand of research and development.
Clinical Laboratory Services Market Country Level Analysis
The clinical laboratory services market is analyzed and market size information is provided by the country specialty, provider, application and service type as referenced above.
The countries covered in the clinical laboratory services market report are South Africa, Saudi Arabia, UAE, Egypt, Israel, and rest of Middle East and Africa.
South Africa is expected to dominate the clinical laboratory services market due to increasing awareness about diagnosis and treatment of the disease.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Middle East and Africa brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Growing Strategic Activities by Major Market Players to Enhance the Awareness for Clinical Laboratory Services is Boosting the Market Growth of Clinical Laboratory Services Market
The clinical laboratory services market also provides with detailed market analysis for every country growth in particular market. Additionally, it provides the detail information regarding the market players’ strategy and their geographical presence. The data is available for historic period 2010-2019.
Competitive Landscape and Clinical Laboratory Services Market Share Analysis
Le paysage concurrentiel du marché des services de laboratoire clinique fournit des détails par concurrent. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements dans la recherche et le développement, les nouvelles initiatives du marché, les sites et installations de production, les forces et les faiblesses de l'entreprise, le lancement de produits, les pipelines d'essais de produits, les approbations de produits, les brevets, la largeur et l'étendue du produit, la domination des applications, la courbe de survie technologique. Les points de données ci-dessus fournis ne concernent que l'orientation de l'entreprise par rapport au marché des services de laboratoire clinique.
Les principales entreprises qui proposent des services de laboratoire clinique sont la Mayo Foundation for Medical Education and Research (MFMER), UNILABS, ACM Middle East and Africa Laboratories et Abbott, entre autres acteurs nationaux. Les analystes de DBMR comprennent les atouts concurrentiels et fournissent une analyse concurrentielle pour chaque concurrent séparément.
De nombreux contrats, accords, collaborations et lancements sont également initiés par les entreprises du monde entier, ce qui accélère également le marché des services de laboratoire clinique.
Par exemple,
- En juillet 2021, Deep Bio, une société leader dans le diagnostic du cancer par intelligence artificielle (IA), a annoncé un accord de collaboration de recherche avec ARUP Laboratories, un laboratoire de référence américain de premier plan et leader mondial dans la recherche et le développement de laboratoires innovants. Cette collaboration a profité à l'entreprise en termes d'utilisation de l'intelligence artificielle dans le diagnostic du cancer.
Le lancement de produits, l'expansion commerciale, les récompenses et la reconnaissance, les coentreprises et d'autres stratégies des acteurs du marché renforcent l'empreinte de l'entreprise sur le marché des services de laboratoire clinique, ce qui offre également l'avantage de la croissance des bénéfices de l'organisation.
SKU-
Accédez en ligne au rapport sur le premier cloud mondial de veille économique
- Tableau de bord d'analyse de données interactif
- Tableau de bord d'analyse d'entreprise pour les opportunités à fort potentiel de croissance
- Accès d'analyste de recherche pour la personnalisation et les requêtes
- Analyse de la concurrence avec tableau de bord interactif
- Dernières actualités, mises à jour et analyse des tendances
- Exploitez la puissance de l'analyse comparative pour un suivi complet de la concurrence
Table des matières
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 OVERVIEW OF ADJACENT BUSINESS
5.1 IMPACT OF POINT OF CARE TESTING MARKET ON CLINICAL LABORATORY TESTING MARKET
5.2 IMPACT OF BIOMETRIC SCREENING MARKET ON CLINICAL LABORATORY TESTING MARKET
5.3 IMPACT OF MOLECULAR DIAGNOSTICS MARKET ON CLINICAL LABORATORY TESTING MARKET
5.4 CONCLUSION
6 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: REGULATIONS
6.1 REGULATION IN THE U.S.
6.2 REGULATION IN EUROPE
6.3 REGULATIONS IN THAILAND
6.4 REGULATIONS IN DUBAI
6.5 REGULATIONS IN INDIA
6.6 REGULATIONS IN CHINA
6.7 REGULATIONS IN JAPAN
6.8 REGULATIONS IN SOUTH AFRICA
7 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: REIMBURSEMENTS
7.1 REIMBURSEMENT IN THE U.S. FOR CLINICAL LABORATORY SERVICES
7.2 REIMBURSEMENT IN INDIA FOR CLINICAL LABORATORY SERVICES
7.3 REIMBURSEMENT IN JAPAN FOR CLINICAL LABORATORY SERVICES
7.4 REIMBURSEMENT IN EUROPE FOR CLINICAL LABORATORY SERVICES
7.5 REIMBURSEMENT IN SOUTH AFRICA FOR CLINICAL LABORATORY SERVICES
8 MARKET OVERVIEW
8.1 DRIVERS
8.1.1 RISE IN INFECTIOUS DISEASES WORLDWIDE
8.1.2 ADVANCEMENT IN CLINICAL DIAGNOSTIC METHODS
8.1.3 DEVELOPMENT IN DATABASE MANAGEMENT TOOLS AND WIDE ACCEPTANCE OF POINT-OF-CARE (POC) TESTING SOLUTIONS
8.1.4 RISE IN DEMAND FOR EARLY AND ACCURATE DISEASE DIAGNOSIS
8.1.5 INCREASE IN APPLICATION OF HIGH-THROUGHPUT ASSAYS
8.2 RESTRAINTS
8.2.1 LACK OF SKILLED AND CERTIFIED PROFESSIONALS
8.2.2 STRICT REGULATORY POLICIES
8.3 OPPORTUNITIES
8.3.1 INCREASE IN ADOPTION OF DIGITAL PATHOLOGY PLATFORMS
8.3.2 RISE IN PREFERENCE FOR PREVENTIVE HEALTH CHECK-UPS
8.3.3 INCREASE IN AWARENESS ABOUT DIAGNOSIS AND TREATMENT OF THE DISEASE
8.3.4 STRATEGIC INITIATIVES BY MARKET PLAYERS
8.4 CHALLENGES
8.4.1 INACCURATE RESULTS OF TESTS
8.4.2 INADEQUATE REIMBURSEMENTS POLICIES
9 IMPACT OF COVID-19 ON MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET
9.1 PRICE IMPACT
9.2 IMPACT ON DEMAND
9.3 IMPACT ON SUPPLY CHAIN
9.4 STRATEGIC DECISIONS FOR MANUFACTURERS
9.5 CONCLUSION
10 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE
10.1 OVERVIEW
10.2 ROUTINE TESTING SERVICES
10.2.1 ROUTINE CHEMISTRY TESTING
10.2.2 ROUTINE HEMATOLOGY TESTING
10.2.3 URINALYSIS TESTING
10.2.4 SUBSTANCE ABUSE TESTING
10.2.5 OTHERS
10.3 ESOTERIC SERVICES
10.4 ANATOMIC PATHOLOGY SERVICES
10.4.1 CYTOLOGY TESTING
10.4.2 DIAGNOSTIC SURGICAL PATHOLOGY TESTING
10.4.3 AUTOPSY PATHOLOGY
10.4.4 OTHERS
11 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY
11.1 OVERVIEW
11.2 CLINICAL CHEMISTRY TESTING
11.2.1 ROUTINE CHEMISTRY TESTING
11.2.2 THERAPEUTIC DRUG MONITORING (TDM) TESTING
11.2.3 SPECIALIZED CHEMISTRY TESTING
11.2.4 OTHER CLINICAL CHEMISTRY TESTING
11.3 HEMATOLOGY TESTING
11.3.1 ROUTINE HEMATOLOGY TESTING
11.3.2 SPECIALIZED HEMATOLOGY TESTING
11.3.3 COAGULATION TESTING
11.4 MICROBIOLOGY TESTING
11.4.1 INFECTIOUS DISEASE TESTING
11.4.2 TRANSPLANT DIAGNOSTIC TESTING
11.4.3 OTHER MICROBIOLOGY TESTING
11.5 IMMUNOLOGY TESTING
11.6 DRUGS OF ABUSE TESTING
11.7 CYTOLOGY TESTING
11.8 GENETIC TESTING
12 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET, BY PROVIDER
12.1 OVERVIEW
12.2 HOSPITAL-BASED LABORATORIES
12.3 INDEPENDENT & REFERENCE LABORATORIES
12.4 NURSING AND PHYSICIAN OFFICE-BASED LABORATORIES
13 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET, BY APPLICATION
13.1 OVERVIEW
13.2 BIOANALYTICAL & LAB CHEMISTRY SERVICES
13.3 DRUG DEVELOPMENT RELATED SERVICES
13.4 DRUG DISCOVERY RELATED SERVICES
13.5 TOXICOLOGY TESTING SERVICES
13.6 CELL & GENE THERAPY RELATED SERVICES
13.7 PRECLINICAL & CLINICAL TRIAL RELATED SERVICES
13.8 OTHER CLINICAL LABORATORY SERVICES
14 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET, BY REGION
14.1 MIDDLE EAST & AFRICA
14.1.1 SOUTH AFRICA
14.1.2 SAUDI ARABIA
14.1.3 U.A.E.
14.1.4 EGYPT
14.1.5 ISRAEL
14.1.6 REST OF MIDDLE EAST & AFRICA
15 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: COMPANY LANDSCAPE
15.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA
16 SWOT ANALYSIS
17 COMPANY PROFILE
17.1 LABORATORY CORPORATION OF AMERICA
17.1.1 COMPANY SNAPSHOT
17.1.2 REVENUE ANALYSIS
17.1.3 COMPANY SHARE ANALYSIS
17.1.4 SERVICE PORTFOLIO
17.1.5 RECENT DEVELOPMENTS
17.2 MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
17.2.1 COMPANY SNAPSHOT
17.2.2 COMPANY SHARE ANALYSIS
17.2.3 SERVICE PORTFOLIO
18.1.1 RECENT DEVELOPMENTS
18.2 DAVITA INC.
18.2.1 COMPANY SNAPSHOT
18.2.2 REVENUE ANALYSIS
18.2.3 COMPANY SHARE ANALYSIS
18.2.4 SERVICE PORTFOLIO
18.2.5 RECENT DEVELOPMENTS
18.3 QUEST DIAGNOSTICS INCORPORATED
18.3.1 COMPANY SNAPSHOT
18.3.2 REVENUE ANALYSIS
18.3.3 COMPANY SHARE ANALYSIS
18.3.4 SERVICE PORTFOLIO
18.3.5 RECENT DEVELOPMENTS
18.4 SONIC HEALTHCARE
18.4.1 COMPANY SNAPSHOT
18.4.2 REVENUE ANALYSIS
18.4.3 SERVICE PORTFOLIO
18.4.4 RECENT DEVELOPMENTS
18.5 ABBOTT
18.5.1 COMPANY SNAPSHOT
18.5.2 REVENUE ANALYSIS
18.5.3 PRODUCT PORTFOLIO
18.5.4 RECENT DEVELOPMENTS
18.6 ACM MIDDLE EAST & AFRICA LABORATORIES
18.6.1 COMPANY SNAPSHOT
18.6.2 SERVICE PORTFOLIO
18.6.3 RECENT DEVELOPMENTS
18.7 AMEDES HOLDING GMBH
18.7.1 COMPANY SNAPSHOT
18.7.2 SERVICE PORTFOLIO
18.7.3 RECENT DEVELOPMENT
18.8 ARUP LABORATORIES
18.8.1 COMPANY SNAPSHOT
18.8.2 SERVICE PORTFOLIO
18.8.3 RECENT DEVELOPMENTS
18.9 BIOREFERENCE LABORATORIES, INC. (A SUBSIDIARY OF OPKO HEALTH, INC.)
18.9.1 COMPANY SNAPSHOT
18.9.2 REVENUE ANALYSIS
18.9.3 SERVICE PORTFOLIO
18.9.4 RECENT DEVELOPMENTS
18.1 CHARLES RIVER
18.10.1 COMPANY SNAPSHOT
18.10.2 REVENUE ANALYSIS
18.10.3 SERVICE PORTFOLIO
18.10.4 RECENT DEVELOPMENTS
18.11 EUROFINS SCIENTIFIC
18.11.1 COMPANY SNAPSHOT
18.11.2 REVENUE ANALYSIS
18.11.3 SERVICE PORTFOLIO
18.11.4 RECENT DEVELOPMENTS
18.12 GENOMIC HEALTH
18.12.1 COMPANY SNAPSHOT
18.12.2 REVENUE ANALYSIS
18.12.3 PRODUCT PORTFOLIO
18.12.4 RECENT DEVELOPMENTS
18.13 H.U. GROUP HOLDINGS, INC.
18.13.1 COMPANY SNAPSHOT
18.13.2 REVENUE ANALYSIS
18.13.3 SERVICE PORTFOLIO
18.13.4 RECENT DEVELOPMENTS
18.14 KINGMED DIAGNOSTICS
18.14.1 COMPANY SNAPSHOT
18.14.2 SERVICE PORTFOLIO
18.14.3 RECENT DEVELOPMENTS
18.15 LIFELABS
18.15.1 COMPANY SNAPSHOT
18.15.2 SERVICE PORTFOLIO
18.15.3 RECENT DEVELOPMENTS
18.16 NEOGENOMICS LABORATORIES, INC.
18.16.1 COMPANY SNAPSHOT
18.16.2 REVENUE ANALYSIS
18.16.3 SERVICE PORTFOLIO
18.16.4 RECENT DEVELOPMENTS
18.17 SIEMENS HEALTHINEERS GMBH
18.17.1 COMPANY SNAPSHOT
18.17.2 REVENUE ANALYSIS
18.17.3 SERVICE PORTFOLIO
18.17.4 RECENT DEVELOPMENTS
18.18 ,SYNLAB INTERNATIONAL GMBH (A SUBSIDIARY OF SYNLAB AG)
18.18.1 COMPANY SNAPSHOT
18.18.2 REVENUE ANALYSIS
18.18.3 SERVICE PORTFOLIO
18.18.4 RECENT DEVELOPMENTS
18.19 NILABS
18.19.1 COMPANY SNAPSHOT
18.19.2 SERVICE PORTFOLIO
18.19.3 RECENT DEVELOPMENTS
19 QUESTIONNAIRE
20 RELATED REPORTS
Liste des tableaux
LIST OF TABLES
TABLE 1 NUMBER OF CORONAVIRUS (COVID-19) TESTS PERFORMED IN THE MOST IMPACTED COUNTRIES WORLDWIDE AS OF JULY 27, 2021
TABLE 2 TYPES AND RATES OF ERROR IN THE 3 STAGES OF THE LABORATORY TESTING PROCESS
TABLE 3 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 4 MIDDLE EAST & AFRICA ROUTINE TESTING SERVICES IN CLINICAL LABORATORY SERVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 5 MIDDLE EAST & AFRICA ROUTINE TESTING SERVICES IN CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE 2019-2028 (USD MILLION)
TABLE 6 MIDDLE EAST & AFRICA ESOTERIC SERVICES IN CLINICAL LABORATORY SERVICES MARKET, BY REGION 2019-2028 (USD MILLION)
TABLE 7 MIDDLE EAST & AFRICA ANATOMIC PATHOLOGY SERVICES IN CLINICAL LABORATORY SERVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 8 MIDDLE EAST & AFRICA ANATOMIC PATHOLOGY SERVICES IN CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE 2019-2028 (USD MILLION)
TABLE 9 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 10 MIDDLE EAST & AFRICA CLINICAL CHEMISTRY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 11 MIDDLE EAST & AFRICA CLINICAL CHEMISTRY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 12 MIDDLE EAST & AFRICA HEMATOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 13 MIDDLE EAST & AFRICA HEMATOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY 2019-2028 (USD MILLION)
TABLE 14 MIDDLE EAST & AFRICA MICROBIOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY REGION 2019-2028 (USD MILLION)
TABLE 15 MIDDLE EAST & AFRICA MICROBIOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY 2019-2028 (USD MILLION)
TABLE 16 MIDDLE EAST & AFRICA IMMUNOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 17 MIDDLE EAST & AFRICA DRUGS OF ABUSE TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY REGION 2019-2028 (USD MILLION)
TABLE 18 MIDDLE EAST & AFRICA CYTOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY REGION 2019-2028 (USD MILLION)
TABLE 19 MIDDLE EAST & AFRICA GENETIC TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY REGION 2019-2028 (USD MILLION)
TABLE 20 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET, BY PROVIDER, 2019-2028 (USD MILLION)
TABLE 21 MIDDLE EAST & AFRICA HOSPITAL-BASED LABORATORIES IN CLINICAL LABORATORY SERVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 22 MIDDLE EAST & AFRICA INDEPENDENT AND REFERENCE LABORATORIES IN CLINICAL LABORATORY SERVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 23 MIDDLE EAST & AFRICA NURSING AND PHYSICIAN OFFICE-BASED LABORATORIES IN CLINICAL LABORATORY SERVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 24 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 25 MIDDLE EAST & AFRICA BIOANALYTICAL AND LAB CHEMISTRY SERVICES IN CLINICAL LABORATORY SERVICES MARKET, BY REGION , 2019-2028 (USD MILLION)
TABLE 26 MIDDLE EAST & AFRICA DRUG DEVELOPMENT RELATED SERVICES IN CLINICAL LABORATORY SERVICES MARKET, BY REGION , 2019-2028 (USD MILLION)
TABLE 27 MIDDLE EAST & AFRICA DRUG DISCOVERY RELATED SERVICES IN CLINICAL LABORATORY SERVICES MARKET, BY REGION , 2019-2028 (USD MILLION)
TABLE 28 MIDDLE EAST & AFRICA TOXICOLOGY TESTING SERVICES IN CLINICAL LABORATORY SERVICES MARKET, BY REGION , 2019-2028 (USD MILLION)
TABLE 29 MIDDLE EAST & AFRICA CELL AND GENE THERAPY RELATED SERVICES IN CLINICAL LABORATORY SERVICES MARKET, BY REGION , 2019-2028 (USD MILLION)
TABLE 30 MIDDLE EAST & AFRICA PRECLINICAL AND CLINICAL TRIAL RELATED SERVICES IN CLINICAL LABORATORY SERVICES MARKET, BY REGION , 2019-2028 (USD MILLION)
TABLE 31 MIDDLE EAST & AFRICA OTHER CLINICAL LABORATORY SERVICES IN CLINICAL LABORATORY SERVICES MARKET, BY REGION , 2019-2028 (USD MILLION)
TABLE 32 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 33 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 34 MIDDLE EAST & AFRICA ROUTINE TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 35 MIDDLE EAST & AFRICA ANATOMIC PATHOLOGY IN CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 36 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 37 MIDDLE EAST & AFRICA CLINICAL CHEMISTRY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 38 MIDDLE EAST & AFRICA MICROBIOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 39 MIDDLE EAST & AFRICA HEMATOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 40 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET, BY PROVIDER, 2019-2028 (USD MILLION)
TABLE 41 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 42 SOUTH AFRICA CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 43 SOUTH AFRICA ROUTINE TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 44 SOUTH AFRICA ANATOMIC PATHOLOGY IN CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 45 SOUTH AFRICA CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 46 SOUTH AFRICA CLINICAL CHEMISTRY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 47 SOUTH AFRICA MICROBIOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 48 SOUTH AFRICA HEMATOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 49 SOUTH AFRICA CLINICAL LABORATORY SERVICES MARKET, BY PROVIDER, 2019-2028 (USD MILLION)
TABLE 50 SOUTH AFRICA CLINICAL LABORATORY SERVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 51 SAUDI ARABIA CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 52 SAUDI ARABIA ROUTINE TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 53 SAUDI ARABIA ANATOMIC PATHOLOGY IN CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 54 SAUDI ARABIA CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 55 SAUDI ARABIA CLINICAL CHEMISTRY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 56 SAUDI ARABIA MICROBIOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 57 SAUDI ARABIA HEMATOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 58 SAUDI ARABIA CLINICAL LABORATORY SERVICES MARKET, BY PROVIDER, 2019-2028 (USD MILLION)
TABLE 59 SAUDI ARABIA CLINICAL LABORATORY SERVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 60 U.A.E. CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 61 U.A.E. ROUTINE TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 62 U.A.E. ANATOMIC PATHOLOGY IN CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 63 U.A.E. CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 64 U.A.E. CLINICAL CHEMISTRY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 65 U.A.E. MICROBIOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 66 U.A.E. HEMATOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 67 U.A.E. CLINICAL LABORATORY SERVICES MARKET, BY PROVIDER, 2019-2028 (USD MILLION)
TABLE 68 U.A.E. CLINICAL LABORATORY SERVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 69 EGYPT CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 70 EGYPT ROUTINE TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 71 EGYPT ANATOMIC PATHOLOGY IN CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 72 EGYPT CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 73 EGYPT CLINICAL CHEMISTRY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 74 EGYPT MICROBIOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 75 EGYPT HEMATOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 76 EGYPT CLINICAL LABORATORY SERVICES MARKET, BY PROVIDER, 2019-2028 (USD MILLION)
TABLE 77 EGYPT CLINICAL LABORATORY SERVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 78 ISRAEL CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 79 ISRAEL ROUTINE TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 80 ISRAEL ANATOMIC PATHOLOGY IN CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 81 ISRAEL CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 82 ISRAEL CLINICAL CHEMISTRY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 83 ISRAEL MICROBIOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 84 ISRAEL HEMATOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 85 ISRAEL CLINICAL LABORATORY SERVICES MARKET, BY PROVIDER, 2019-2028 (USD MILLION)
TABLE 86 ISRAEL CLINICAL LABORATORY SERVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 87 REST OF MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
Liste des figures
LIST OF FIGURES
FIGURE 1 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: SEGMENTATION
FIGURE 2 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: DATA TRIANGULATION
FIGURE 3 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: DROC ANALYSIS
FIGURE 4 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: MIDDLE EAST & AFRICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: DBMR MARKET POSITION GRID
FIGURE 8 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET APPLICATION COVERAGE GRID
FIGURE 9 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: SEGMENTATION
FIGURE 11 RISING INFECTIOUS DISEASES WORLDWIDE AND RISING DEMAND FOR EARLY AND ACCURATE DISEASE DIAGNOSIS ARE EXPECTED TO DRIVE THE MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 12 ROUTINE TESTING SERVICES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET IN 2021 & 2028
FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE THE MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET, AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET
FIGURE 15 BELOW ARE BENEFITS THAT HAVE TO INCREASE THE ADOPTION OF DIGITAL PATHOLOGY PLATFORMS:
FIGURE 16 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: BY SERVICE TYPE, 2020
FIGURE 17 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: BY SERVICE TYPE, 2020-2028 (USD MILLION)
FIGURE 18 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: BY SERVICE TYPE, CAGR (2021-2028)
FIGURE 19 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: BY SERVICE TYPE, LIFELINE CURVE
FIGURE 20 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: BY SPECIALTY, 2020
FIGURE 21 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: BY SPECIALTY, 2020-2028 (USD MILLION)
FIGURE 22 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: BY SPECIALTY, CAGR (2021-2028)
FIGURE 23 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: BY SPECIALTY, LIFELINE CURVE
FIGURE 24 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: BY PROVIDER, 2020
FIGURE 25 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: BY PROVIDER, 2020-2028 (USD MILLION)
FIGURE 26 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: BY PROVIDER, CAGR (2020-2028)
FIGURE 27 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: BY PROVIDER, LIFELINE CURVE
FIGURE 28 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: BY APPLICATION, 2020
FIGURE 29 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: BY APPLICATION, 2020-2028 (USD MILLION)
FIGURE 30 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: BY APPLICATION, CAGR (2020-2028)
FIGURE 31 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 32 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: SNAPSHOT (2020)
FIGURE 33 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: BY COUNTRY (2020)
FIGURE 34 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: BY COUNTRY (2021 & 2028)
FIGURE 35 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: BY COUNTRY (2020 & 2028)
FIGURE 36 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: BY SERVICE TYPE (2021 & 2028)
FIGURE 37 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: COMPANY SHARE 2020 (%)
Méthodologie de recherche
La collecte de données et l'analyse de l'année de base sont effectuées à l'aide de modules de collecte de données avec des échantillons de grande taille. L'étape consiste à obtenir des informations sur le marché ou des données connexes via diverses sources et stratégies. Elle comprend l'examen et la planification à l'avance de toutes les données acquises dans le passé. Elle englobe également l'examen des incohérences d'informations observées dans différentes sources d'informations. Les données de marché sont analysées et estimées à l'aide de modèles statistiques et cohérents de marché. De plus, l'analyse des parts de marché et l'analyse des tendances clés sont les principaux facteurs de succès du rapport de marché. Pour en savoir plus, veuillez demander un appel d'analyste ou déposer votre demande.
La méthodologie de recherche clé utilisée par l'équipe de recherche DBMR est la triangulation des données qui implique l'exploration de données, l'analyse de l'impact des variables de données sur le marché et la validation primaire (expert du secteur). Les modèles de données incluent la grille de positionnement des fournisseurs, l'analyse de la chronologie du marché, l'aperçu et le guide du marché, la grille de positionnement des entreprises, l'analyse des brevets, l'analyse des prix, l'analyse des parts de marché des entreprises, les normes de mesure, l'analyse globale par rapport à l'analyse régionale et des parts des fournisseurs. Pour en savoir plus sur la méthodologie de recherche, envoyez une demande pour parler à nos experts du secteur.
Personnalisation disponible
Data Bridge Market Research est un leader de la recherche formative avancée. Nous sommes fiers de fournir à nos clients existants et nouveaux des données et des analyses qui correspondent à leurs objectifs. Le rapport peut être personnalisé pour inclure une analyse des tendances des prix des marques cibles, une compréhension du marché pour d'autres pays (demandez la liste des pays), des données sur les résultats des essais cliniques, une revue de la littérature, une analyse du marché des produits remis à neuf et de la base de produits. L'analyse du marché des concurrents cibles peut être analysée à partir d'une analyse basée sur la technologie jusqu'à des stratégies de portefeuille de marché. Nous pouvons ajouter autant de concurrents que vous le souhaitez, dans le format et le style de données que vous recherchez. Notre équipe d'analystes peut également vous fournir des données sous forme de fichiers Excel bruts, de tableaux croisés dynamiques (Fact book) ou peut vous aider à créer des présentations à partir des ensembles de données disponibles dans le rapport.
